ORA.TO vs. NBIX

Last updated Jun 4, 2026

ORA.TO (Aura Minerals Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. ORA.TO operates in Gold (Basic Materials), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). At a 0.00 correlation, their price movements are largely independent.

Performance

ORA.TO vs. NBIX - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Aura Minerals Inc. (ORA.TO) and Neurocrine Biosciences, Inc. (NBIX). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

ORA.TO is traded in CAD, while NBIX is traded in USD. To make them comparable, the NBIX values have been converted to CAD using the latest available exchange rates.

Returns By Period

ORA.TO

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NBIX

• 1D: 7.07%
• 1M: 25.61%
• YTD: 17.90%
• 6M: 8.23%
• 1Y: 33.79%
• 3Y*: 22.80%
• 5Y*: 15.03%
• 10Y*: 13.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ORA.TO vs. NBIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ORA.TO Aura Minerals Inc.	0.00%	173.17%	103.33%	22.50%	-21.12%	-20.62%	764.03%	40.82%	-24.90%	57.66%
NBIX Neurocrine Biosciences, Inc.	17.90%	-0.86%	12.50%	7.88%	50.23%	-11.95%	-12.34%	43.13%	-0.16%	87.72%

Correlation

The correlation between ORA.TO and NBIX is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.01
Correlation (10Y) Calculated over the trailing 10-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Jun 23, 2009	0.00

Fundamentals

Market Cap ORA.TO : CA$3.46B NBIX : $17.07B
EPS ORA.TO : -CA$0.80 NBIX : $6.53
PS Ratio ORA.TO : 5.08 NBIX : 5.45
PB Ratio ORA.TO : 24.73 NBIX : 5.01
Total Revenue (TTM) ORA.TO : CA$679.91M NBIX : $3.10B
Gross Profit (TTM) ORA.TO : CA$335.65M NBIX : $3.05B
EBITDA (TTM) ORA.TO : CA$127.50M NBIX : $881.20M

Return for Risk

ORA.TO vs. NBIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIX

NBIX Risk / Return Rank: 68
NBIX Sharpe Ratio Rank: 72
NBIX Sortino Ratio Rank: 66
NBIX Omega Ratio Rank: 67
NBIX Calmar Ratio Rank: 69
NBIX Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORA.TO vs. NBIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aura Minerals Inc. (ORA.TO) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ORA.TO	NBIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.08	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.46	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.35	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.54	—

Drawdowns

Drawdown Indicators

	ORA.TO	NBIX	Difference
Max Drawdown Largest peak-to-trough decline	—	-50.15%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-23.34%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-43.75%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-43.75%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-50.15%	—
Current Drawdown Current decline from peak	—	0.00%	—
Average Drawdown Average peak-to-trough decline	—	-18.98%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	10.64%	—

Volatility

Volatility by Period

	ORA.TO	NBIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	12.74%	—
Volatility (6M) Calculated over the trailing 6-month period	—	23.74%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	31.32%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	32.74%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	38.93%	—

Dividends

ORA.TO vs. NBIX - Dividend Comparison

ORA.TO's dividend yield for the trailing twelve months is around 1.00%, while NBIX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
NBIX Neurocrine Biosciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ORA.TO Aura Minerals Inc.	1.00%	3.00%	4.63%	5.63%	4.67%	14.10%	0.00%	3.57%

Financials

ORA.TO vs. NBIX - Profitability Comparison

The chart below illustrates the profitability comparison between Aura Minerals Inc. and Neurocrine Biosciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ORA.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. reported a gross profit of 103.94M and revenue of 190.44M. Therefore, the gross margin over that period was 54.6%.

NBIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.

ORA.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. reported an operating income of 90.94M and revenue of 190.44M, resulting in an operating margin of 47.8%.

NBIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.

ORA.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. reported a net income of 8.15M and revenue of 190.44M, resulting in a net margin of 4.3%.

NBIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.

Frequently Asked Questions

Can I hold both ORA.TO and NBIX in my portfolio?

ORA.TO and NBIX have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.